Article Abstract

Invited author response to editorials on liposomal bupivacaine in minimally-invasive thoracic surgery: the judge is in favor but the jury is still out

Authors: Sora Ely, Dana A. Dominguez, Jeffrey B. Velotta


We appreciate the insightful editorials by Martin and Mehran (1) and Caso and Marshall (2) regarding our recent manuscript (3), which described a decreased length of stay (LOS) in patients receiving intercostal nerve blocks with liposomal bupivacaine (LB) (Exparel®) compared to standard bupivacaine after video-assisted thoracoscopic surgery (VATS) or minimally-invasive esophagectomy (MIE). Both articles raise a number of interesting points, and we would like to clarify some details of our study and expand on their discussion.